Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

John David Finley

CEO, CFO at Palisade Bio, Inc. (PALI)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $311K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 8SEC PALIPalisade Bio, Inc. Sell 146,798217,555 held (−40%) $2.07 $304K -31.9%
Feb 13SEC PALIPalisade Bio, Inc. Sell 3,89627,353 held (−12%) $1.75 $7K -19.4%
  • Sell

    CEO, CFO John David Finley sold $304K of PALI at $2.07 — cuts the stake by 40%.